Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Evolus Inc’s stock clocked out at $7.38, down -1.60% from its previous closing price of $7.5. In other words, the price has decreased by -$1.60 from its previous closing price. On the day, 1.04 million shares were traded. EOLS stock price reached its highest trading level at $7.52 during the session, while it also had its lowest trading level at $7.185.
Ratios:
To gain a deeper understanding of EOLS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 2.27.
On April 17, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $21.
Barclays Upgraded its Equal Weight to Overweight on January 29, 2024, whereas the target price for the stock was revised from $10 to $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’25 when Yamagishi-Dressler Tomoko sold 5,722 shares for $7.51 per share. The transaction valued at 42,972 led to the insider holds 89,949 shares of the business.
Stewart Brady bought 30,000 shares of EOLS for $204,486 on Aug 15 ’25. The Director now owns 88,629 shares after completing the transaction at $6.82 per share. On Jun 13 ’25, another insider, MOATAZEDI DAVID, who serves as the insider of the company, sold 111,323 shares for $10.05 each. As a result, the insider received 1,119,141 and left with 381,509 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 477378272 and an Enterprise Value of 570546368. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72. Its current Enterprise Value per Revenue stands at 2.053 whereas that against EBITDA is -16.219.
Stock Price History:
The Beta on a monthly basis for EOLS is 1.09, which has changed by -0.5073431 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $5.71. The 50-Day Moving Average of the stock is -11.72%, while the 200-Day Moving Average is calculated to be -32.57%.
Shares Statistics:
It appears that EOLS traded 1.36M shares on average per day over the past three months and 917910 shares per day over the past ten days. A total of 64.64M shares are outstanding, with a floating share count of 50.82M. Insiders hold about 21.44% of the company’s shares, while institutions hold 86.59% stake in the company. Shares short for EOLS as of 1755216000 were 10683088 with a Short Ratio of 7.84, compared to 1752537600 on 12630982. Therefore, it implies a Short% of Shares Outstanding of 10683088 and a Short% of Float of 16.870001000000002.
Earnings Estimates
Current recommendations for the stock of the company come from 3.0 analysts. The consensus estimate for the next quarter is $0.07, with high estimates of $0.13 and low estimates of $0.03.
Analysts are recommending an EPS of between -$0.45 and -$0.83 for the fiscal current year, implying an average EPS of -$0.55. EPS for the following year is $0.15, with 5.0 analysts recommending between $0.23 and $0.0.
Revenue Estimates
In the current quarter, 6 analysts expect revenue to total $67.72M. It ranges from a high estimate of $71.01M to a low estimate of $65.3M. As of the current estimate, Evolus Inc’s year-ago sales were $61.09MFor the next quarter, 6 analysts are estimating revenue of $91.34M. There is a high estimate of $93.62M for the next quarter, whereas the lowest estimate is $89M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $302.54M, while the lowest revenue estimate was $294.6M, resulting in an average revenue estimate of $297.62M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $385.3M in the next fiscal year. The high estimate is $409M and the low estimate is $369.5M.
